Animal Vaccine Market to Surpass $ 8 Billion by 2025
Rising diseases in animals
to drive global animal vaccine market
According
to TechSci Research report, “Global Animal
Vaccine Market By Animal Type, By Technology, By Disease, By Route of
Administration, By Distribution Channel, By Region, Competition, Forecast &
Opportunities, 2025”, the global animal vaccine market is forecast to
cross $ 8 billion by 2025. Continuously growing population of companion animals, livestock, swine, etc.,
coupled with growing consumption of meat across the globe is
boosting the growth of global animal vaccine market. Along with
this, supportive government funding, reimbursement policies and increasing
investments by public and private bodies are expected to fuel the market growth
during the next five years. However, there are some factors that can act as
major impediments to the growth of global animal vaccine market through 2025
such as concerns pertaining to reimbursement policies and regulatory scenarios.
Browse 208 market data Figures spread through 130 Pages and an in-depth TOC on "Global Animal Vaccine Market "
https://www.techsciresearch.com/report/animal-vaccine-market/5071.html
Global animal vaccine market is
segmented on the basis of animal type, technology, disease, route of
administration, distribution channel, and region. Based on animal type, the
market is further segmented into livestock, swine, poultry, companion animals,
and others, with livestock dominating the global animal vaccine market,
followed by swine and poultry segments. The inactive
vaccine segment dominated the global animal vaccine market in 2019 and is
further anticipated to maintain its dominance during the forecast period as
well. In term of route of administration, the market is segregated into subcutaneous,
intramuscular, intraocular, oral and others. Out of these, subcutaneous segment
accounted for largest market share until 2019 and is further anticipated to
grow at a higher pace in the years to come.
Zoetis, Inc., Boehringer Ingelheim
International GmbH, Elanco Animal Health Incorporated, Merck & Co., Inc.,
Ceva Sante Animale SA, Bayer AG, Virbac SA, Neogen Corporation, ImmuCell
Corporation, and Covetrus, Inc. are among the leading players
operating in the global animal vaccine market. The market players are adopting several
growth strategies to enhance their market share such as product launches,
mergers & acquisitions, agreements, partnerships, and collaborations.
Download
sample report @ https://www.techsciresearch.com/sample-report.aspx?cid=5071
customers can also
request for 10% free customization on this report.
“North America is forecast to dominate the global animal vaccine market though
2025 on account of rapid testing and trails in the region. Furthermore, rising spending
on healthcare, presence of advanced clinical laboratories and medical device
manufacturing companies coupled with favorable government policies are also
contributing to the growing trend. Additionally, Asia-Pacific is forecast to
register fastest CAGR among all the regions over the next five years, which can
be attributed to expanding research and development facilities in the field of
animal vaccine.”, said Mr. Karan Chechi, Research Director with TechSci
Research, a research based global management consulting firm.
“Global
Animal Vaccine Market By Animal Type, By Technology, By Disease, By Route of
Administration, By Distribution Channel, By Region, Competition, Forecast &
Opportunities, 2025” has
evaluated the future growth potential of global animal vaccine market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers, challenges,
and opportunities in the global animal vaccine market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]